Carcinoma, Basal Cell (BCC)

1

Review clinical trials related to Carcinoma, Basal Cell (BCC). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice

Basal cell carcinoma (BCC) is the most common skin cancer in the Netherlands, with incidence rates continuing to rise. The current diagnostic standard combines clinical evaluation and dermoscopy, while biopsy followed by histopathological examination remains the gold standard when uncertainty about the diagnosis persists. However, biopsy is invasive, time-consuming, and costly. Line-field confocal optical coherence tomography (LC-OCT) is a non-invasive imaging technique that has emerged as a promising alternative to biopsy for BCC suspected lesions. This retrospective study aims to evaluate the real-world clinical performance of LC-OCT in routine dermatological practice, where it has been integrated into the diagnostic work-up for BCC-suspect lesions.

Participants needed: 297
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Maastricht University Medical CenterUpdated: Mar 30, 2026Locations: 1
Eligibility criteria

Patients aged ≥18 years [+2]

Patients <18 years of age [+1]